@MrFantastic keep the faith, we’re on the same page and team IMO.
There was a fascinating article in the AFR over the weekend on Resmed, which as we all know built their business around the CPAP technology.
This is a massive sector. Resmed generated net income of US$280m for 6 months (up 22%) and have a US$26 billion market cap. Resmed also believe they have only penetrated 5% of the accessible market.
If IHL release any positive news on the OSA trial then the share price will absolutely explode. I understand this is early stage but that’s also why you can buy shares at this price.
IHL Price at posting:
6.4¢ Sentiment: Buy Disclosure: Held
